Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Modera...

por Prasenohadi, Prasenohadi, Burhan, Erlina, Dhunny, Sri, Suharno, Wahyuningsih, Wabnitz, Paul, Kim, Yoon-Won, Petrosillo, Nicola
Publicado 2022